Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$216M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
KeyCorp
KEY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 5 |
Synchrony
SYF
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.82B |
| 2 |
Comcast
CMCSA
|
+$427M |
| 3 |
Amazon
AMZN
|
+$418M |
| 4 |
SLB Ltd
SLB
|
+$312M |
| 5 |
Ameren
AEE
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.36% |
| 2 | Energy | 10.86% |
| 3 | Financials | 9.53% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Technology | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Burlington
BURL
$20.6B
| $17.7M | 0.04% |
411,849
+167,692
| +69% | +$7.77M |
|
|
PKY
627
DELISTED
Parkway, Inc.
PKY
| $17.7M | 0.04% |
1,129,565
-260,026
| -19% | -$4.27M |
|
628
Herc Holdings
HRI
$5.41B
| $17.6M | 0.04% |
411,268
+387,988
| +1,667% | +$19.5M |
|
|
629
CALL
DuPont de Nemours
DD
$18.7B
| $17.5M | 0.04% |
134,260
+35,540
| +36% | +$4.56M |
|
630
Archrock
AROC
$5.58B
| $17.5M | 0.04% |
2,323,880
-417,713
| -15% | -$5.97M |
|
631
Workday
WDAY
$49.4B
| $17.4M | 0.04% |
218,514
+125,551
| +135% | +$10M |
|
|
CNCE
632
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $17.4M | 0.04% |
915,625
-55,394
| -6% | -$1.2M |
|
|
WOOF
633
DELISTED
VCA Inc.
WOOF
| $17.3M | 0.04% |
314,885
-316,957
| -50% | -$17.4M |
|
634
DigitalBridge
DBRG
$2.95B
| $17.3M | 0.04% |
355,828
-55,959
| -14% | -$3.01M |
|
635
Lear
LEA
$8.56B
| $17.3M | 0.04% |
140,538
+52,491
| +60% | +$6.39M |
|
|
AET
636
DELISTED
Aetna Inc
AET
| $17.2M | 0.04% |
158,792
-537,812
| -77% | -$58.1M |
|
637
Karyopharm Therapeutics
KPTI
$44.5M
| $17.1M | 0.04% |
86,290
+17,908
| +26% | +$3.88M |
|
638
Republic Services
RSG
$67.6B
| $17.1M | 0.04% |
389,537
-134,157
| -26% | -$5.85M |
|
639
Novartis
NVS
$302B
| $17.1M | 0.04% |
221,219
+73,365
| +50% | +$5.83M |
|
|
ANAC
640
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $17M | 0.04% |
150,537
-1,035,070
| -87% | -$114M |
|
641
Sunstone Hotel Investors
SHO
$2.1B
| $17M | 0.04% |
1,357,458
+1,334,859
| +5,907% | +$18.9M |
|
|
OTIC
642
DELISTED
Otonomy, Inc.
OTIC
| $16.9M | 0.04% |
609,929
+585,693
| +2,417% | +$14.6M |
|
|
QTS
643
DELISTED
QTS REALTY TRUST, INC.
QTS
| $16.9M | 0.04% |
373,914
-40,576
| -10% | -$1.77M |
|
|
IMPV
644
DELISTED
Imperva, Inc.
IMPV
| $16.8M | 0.04% |
264,863
+175,472
| +196% | +$11.9M |
|
645
Bank of Montreal
BMO
$122B
| $16.8M | 0.04% |
297,071
-259,149
| -47% | -$14.9M |
|
646
Whirlpool
WHR
$2.63B
| $16.7M | 0.04% |
113,971
-337,441
| -75% | -$52.4M |
|
|
STRZA
647
DELISTED
Starz - Series A
STRZA
| $16.7M | 0.04% |
+499,221
| New | +$17.8M |
|
648
Orthofix Medical
OFIX
$408M
| $16.6M | 0.04% |
424,249
+94,442
| +29% | +$3.53M |
|
649
Old Republic International
ORI
$10B
| $16.4M | 0.03% |
878,141
+147,330
| +20% | +$2.65M |
|
650
Acadia Pharmaceuticals
ACAD
$5.08B
| $16.4M | 0.03% |
458,785
-336,240
| -42% | -$11.8M |
|
Similar funds
Israel Englander's Q4 2015 Portfolio in Review
As of Q4 2015, Israel Englander held 4,144 positions worth $47.6B, down 7.9% from $51.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander withdrew a net $5.89B in Q4 2015, closing 778 positions and reducing 1,349 holdings. Its most notable exit was Illumina, an estimated $86.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Energy and Financials.
Against the trend, Israel Englander opened a new position in Alphabet (Google) Class A worth $221M.
- Israel Englander's largest Q4 2015 buy was Alphabet (Google) Class A: 5,673,120 shares worth $221M.
- Israel Englander added most to Merck in Q4 2015, an estimated $216M increase.
- Israel Englander's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $1.82B.
- Israel Englander fully exited Illumina in Q4 2015, selling an estimated $86.9M.
- Israel Englander's ten largest holdings make up 10% of its $47.6B portfolio in Q4 2015.
- Israel Englander opened 733 new positions and closed 778 in Q4 2015.
- Israel Englander's portfolio value fell 7.9% quarter-over-quarter to $47.6B.
Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.